Quarterly results
2019 Full year and fourth quarter
We will announce our 2019 full year and fourth quarter results at 12:00 GMT, 07:00 EST on Wednesday 05 February
Following the announcement, there will be a webcast hosted by Emma Walmsley, CEO, and other members of CET at 14:00 GMT, 09:00 EST.
-
2010 Third Quarter - released 21 October 2010
Andrew Witty, CEO, discusses our third quarter results 2010
Key highlights
- Q3 EPS before major restructuring of 28.2p
- Q3 dividend up 7% to 16p
-
2010 Second Quarter - released 21 July 2010
Andrew Witty, CEO, discusses our second quarter results 2010.
Key highlights
- Q2 EPS before major restructuring 2.6p (29.3p excluding pre-announced legal charge)
- Q2 dividend increased 7% to 15p
-
2010 First Quarter - released 28 April 2010
Andrew Witty, CEO, discusses our first quarter results 2010.
Key highlights
- Q1 sales £7.4bn up 13% CER
- Underlying sales (excluding pandemic products) up 4% CER
Other key information
-
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
-
Press releases
Keep up to date with our news and recent announcements
-
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
-
Our pipeline
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients and payers.
